A 19-year-old woman’s breasts stunningly grew from a B cup to a triple G in the six months following her Pfizer COVID-19 vaccination in what researchers are calling a first-of-its-kind case.

Court revives lawsuit against Pfizer's diversity fellowship Group claims Pfizer program discriminates against white, Asian-American applicants Pfizer defends diversity efforts, lawsuit follows ...

Now, Pfizer and the trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) rank among the organizations that have helped Trump raise a record-setting $150 million in pledges ...

Shares of UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) continued to trade lower on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla reiterated remarks made by President-elect Donald Trump ...

you’re eligible to get a Pfizer booster shot, the CDC says. Right now, the Pfizer vaccine is the only one available to people below the age of 18, so adolescents don’t need to worry about the ...

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...

Pfizer's stock has underperformed, but management's focus on R&D and cost efficiencies should boost margins and free cash flow, supporting a Buy rating. Despite political headwinds, PFE's ...

Pfizer's management team recently announced sales and earnings expectations for 2025. An investment-bank analyst thinks Pfizer stock can shoot about 37% higher in 2025. Pfizer has raised its ...

They even generated clinical results that suggested it might have promise as a weight-loss drug as well — only to have Pfizer, which had agreed to fund the research, withdraw its support ...

After pulling off a surprise third-quarter beat and full-year guidance raise amid shareholder activism earlier this year, Pfizer now expects its 2025 revenues to come in the same range as in 2024.

Beata Zawrzel / NurPhoto via Getty Images Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.